Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update
A Greinacher, TE Warkentin - Thrombosis research, 2006 - Elsevier
Heparin-induced thrombocytopenia (HIT) is one of the most important life-and limb-
threatening adverse drug events encountered by physicians. Serious sequelae associated …
threatening adverse drug events encountered by physicians. Serious sequelae associated …
Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians …
Background Heparin-induced thrombocytopenia (HIT) is an antibody-mediated adverse
drug reaction that can lead to devastating thromboembolic complications, including …
drug reaction that can lead to devastating thromboembolic complications, including …
Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
TE Warkentin, A Greinacher - Chest, 2004 - Elsevier
This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Seventh ACCP Conference on Antithrombotic and …
thrombocytopenia (HIT) is part of the Seventh ACCP Conference on Antithrombotic and …
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines
TE Warkentin, A Greinacher, A Koster, AM Lincoff - Chest, 2008 - Elsevier
This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American …
thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American …
Treatment of heparin-induced thrombocytopenia: a critical review
Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy that
has a high rate of morbidity (thrombosis and amputation) and mortality. In the past, a number …
has a high rate of morbidity (thrombosis and amputation) and mortality. In the past, a number …
Benefit-risk assessment of treatments for heparin-induced thrombocytopenia
HL Messmore, WP Jeske, WH Wehrmacher… - Drug safety, 2003 - Springer
Patients with heparin-induced thrombocytopenia (HIT) are at high risk of thrombosis and
should be treated with alternative anticoagulant therapy to reduce complications. The …
should be treated with alternative anticoagulant therapy to reduce complications. The …
Preventing complications in heparin-induced thrombocytopenia: alternative anticoagulants are improving patient outcomes
L Rice, PH Nguyen, AR Vann - Postgraduate medicine, 2002 - Taylor & Francis
PREVIEW Delays in treatment of heparin-induced thrombocytopenia (HIT), the most
common serious drug reaction in hospitals, contribute to poor patient outcomes. Fortunately …
common serious drug reaction in hospitals, contribute to poor patient outcomes. Fortunately …
Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management
Heparin-induced thrombocytopenia (HIT) is a life and limb-threatening complication of
heparin exposure. Here, we review the pathogenesis, incidence, diagnosis, and …
heparin exposure. Here, we review the pathogenesis, incidence, diagnosis, and …
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses
Heparin-induced thrombocytopenia (HIT) is a prothrombotic adverse drug reaction occurring
in< 0.1% to 7% of patients receiving heparin products depending on the patient population …
in< 0.1% to 7% of patients receiving heparin products depending on the patient population …
Heparin-induced thrombocytopenia: an update
M Prechel, JM Walenga - Seminars in thrombosis and …, 2012 - thieme-connect.com
Heparin-induced thrombocytopenia (HIT) is an immune response to heparin that can
progress to severe thrombosis, amputation, and in some cases death. The diagnosis and …
progress to severe thrombosis, amputation, and in some cases death. The diagnosis and …